Clinical trial
Study of the Ability of a Flu Vaccine to Prevent Flu Infection
NCT00349037 · PowderMed, Industry · Completed
Key facts
| NCT number | NCT00349037 |
|---|---|
| Title | Study of the Ability of a Flu Vaccine to Prevent Flu Infection |
| Official title | A Prospective, Randomised, Double Blind, Placebo-Controlled Study to Assess the Efficacy of a Trivalent (A/New Caledonia/20/99, A/Panama/2007/99, B/Jiangsu/10/20) DNA Influenza Vaccine Administered by Particle Mediated Epidermal Delivery (PMED) Against a Controlled Influenza Virus Challenge. |
| Lead sponsor | PowderMed, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Trivalent DNA vaccine with and without pPJV2012 administered by PMED |
| Enrollment | 105 |
| Start date | Sep 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Jul 6, 2006 |
| Last update posted | Jan 29, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: